Esperite N.V.
Stock Exchange Euronext - Alternext Amsterdam
EPS
-
Market Cap
EUR2.72 M
Shares Outstanding
39.66 M
Public Float
-

Profile

Address
Herengracht 282
Amsterdam Noord-Holland 1016 BX
Netherlands
Employees -
Website http://www.esperite.com
Updated 07/08/2019
Esperite NV engages in regenerative and predictive medicine. It operates through the following business segments: The extraction and storage of adult human stem cells, Research and Development, Predictive medicine, and Other types of products and services. The extraction and storage of adult human stem cells segment refers to the tem cells collected from the umbilical cord blood, and the umbilical cord itself, at birth and from adipose tissue.

Financials

View All
Created with Highcharts 5.0.14Esperite N.V.Net Income. Fiscal year is January-December. All values EUR Thousands.17 10317 1033 5133 5135 0145 0147 0577 0578 4078 40712 72212 72220122013201420152016201705k10k15k20k
Created with Highcharts 5.0.14Esperite N.V.Sales/Revenue. Fiscal year is January-December. All values EUR Thousands.36 84236 84229 81429 81427 61027 61027 51927 51926 25426 25416 55316 553201220132014201520162017010k20k30k40k

Gert-Jan van der Marel
Chairman
Frédéric A. Amar
Chief Executive Officer & Executive Director